Skip to main content
. 2019 Oct 31;45(1):131–140. doi: 10.3892/ijmm.2019.4390

Figure 7.

Figure 7

Suppression of tumor growth by silencing the MyD88 gene in the HCT116 cells subcutaneous xenografts. Three groups (pLKO.1 and pLKO.1-sh3 groups) were subcutaneous xenografted onto nude mice. (A) The tumor growth of pLKO.1-sh3 group was significantly inhibited compared with pLKO.1 group. (B) The size of the primary tumors was measured every 4 days. Mice were sacrificed after 5 weeks. (C) The weights of tumors were weighed. Significant differences were identified between the pLKO.1 and pLKO.1-sh3 groups. (D) Immunohistochemical analysis of the expression of MyD88 in HCT116 cell subcutaneous xenograft tumors. Staining showed expression of MyD88 (×100 and ×200) in pLKO.1 and pLKO.1-sh3 groups. (E) Quantitative evaluation of the expression of MyD88. Bars show the MyD88 staining area ration/per field. Marked differences between the pLKO.1 and pLKO.1-sh3 groups were identified. *P<0.05, **P<0.01.